Germeni, Evi
Cooper, Jacie
Briggs, Andrew
Laurence, Jeffrey
Article History
Received: 16 April 2024
Accepted: 23 September 2024
First Online: 14 November 2024
Declarations
:
: The study was approved by the Biomedical Research Alliance of New York LLC Organizational Review Board and the Weill Cornell Institutional Review Board (Study Protocol: 21-07023785). Written informed consent was obtained from all experts participating in the interviews.
: The consent process involved informing all participants that interviews would form the basis of a publication and that no identifying information would be used.
: AB and JL have received consultancy payments from Alexion Pharmaceuticals in addition to the funding reported here.